vemurafenib

The drug is indicated for monotherapy of unresectable or metastatic melanoma in which a BRAF V600 mutation has been detected.

Form: tablets, film-coated

ATC: L01EC01

Manufacturer: Delpharm Milano, S.R.L. (manufacturing of unpackaged products, primary packaging, secondary packaging, quality control testing)